| Z-1694-2024 | Class II | Keller Funnel 2, REF: HA-001, STERILEEO, Rx Only, | March 14, 2024 |
| D-1056-2019 | Class II | Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% 5 mL bottles, Rx only, | March 19, 2019 |
| D-0077-2018 | Class III | Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%, Rx only, packaged in | October 19, 2017 |
| D-0078-2018 | Class III | Lumigan (bimatoprost ophthalmic solution) 0.01%, 2.5 mL bottle, Rx only, Allergan, Irvine, CA 92612 | October 19, 2017 |
| D-0929-2017 | Class II | Blephamide (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10%/0.2% sterile | May 1, 2017 |
| D-0667-2017 | Class III | Lumigan (bimatoprost ophthalmic solution) 0.01%, 7.5 mL bottle, Rx only, Allergan Irvine, CA 92612, | March 16, 2017 |
| D-0099-2017 | Class II | TAZORAC (tazarotene) Gel 0.05%, Rx only, For Dermatologic Use Only, Not for Ophthalmic Use, packaged | June 30, 2016 |
| D-0100-2017 | Class II | TAZORAC (tazarotene) Gel 0.05%, Rx only, packaged in 15 x 3.5 g professional sample containers, Manu | June 30, 2016 |
| D-1064-2016 | Class II | Tazorac (tazarotene) Gel 0.05%, Rx only, packaged in a) 30g (NDC 0023-8335-03) and b) 100g (NDC 0023 | May 10, 2016 |
| D-1065-2016 | Class II | Tazorac (tazarotene) Gel 0.05%, 15 x 3.5g, sample packs, Allergan Inc, Irvine, CA 92612. UPC 300238 | May 10, 2016 |
| D-1819-2015 | Class II | FML (fluorometholone ophthalmic ointment) 0.1%, 3.5 g tube, Rx only, Allergan, Inc., Irvine, CA 926 | August 24, 2015 |
| D-1818-2015 | Class II | Refresh P.M. (Mineral Oil 42.5% and White Petrolatum 57.3%) Lubricant Eye Ointment, Net wt. 0.12 oz | August 24, 2015 |
| D-1817-2015 | Class II | Refresh Lacri-Lube (Mineral Oil 42.5% and White Petrolatum 56.8%) Lubricant Eye Ointment, packaged i | August 24, 2015 |
| D-1820-2015 | Class II | BLEPHAMIDE (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10 %/0.2 %, 3.5 | August 24, 2015 |